(Reuters) - But the results topped the average Wall Street forecast, making Abbott the fourth large U.S. drugmaker this month to report earnings above analysts' estimates.
Excluding special items, Abbott earned 55 cents per share. Analysts' average forecast was 52 cents, according to Reuters Estimates.
Read more at Reuters.com Market News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment